Posted in | News | Gold | Mining Business

Lexam VG Share Owners Approve The Acquisition By Mcewen Mining

Lexam VG Gold Inc. is pleased to announce that its Share Owners voted in favour of the Arrangement Agreement for the acquisition of Lexam VG by McEwen Mining Inc. at its Special Meeting of Shareholders today.

A total of 46.1% of Lexam's 226,570,860 issued and outstanding shares were voted. Lexam VG Share Owners approved the resolution approving the arrangement by a wide margin. To be effective, the arrangement resolution required the approval of:

  • At least 66 2/3% of the votes cast on the resolution to approve the Arrangement by the Lexam Shareholders present in person or represented by proxy and entitled to vote at the Meeting. Results of this vote are as follows:

and

  • At least a majority of the votes cast on the resolution to approve the Arrangement by the minority Lexam Shareholders present in person or represented by proxy and entitled to vote at the Meeting. The minority Shareholders exclude the shares of Lexam held by Rob McEwen:

The formal report of the voting results of the Meeting will also be filed on the SEDAR website at www.sedar.com.

Next Steps in the Transaction

The TSX Exchange has conditionally approved the arrangement transaction. Application for approval is also being made by McEwen Mining of the NYSE. The arrangement transaction also requires a final order of the Ontario Superior Court of Justice. A Notice of Application for the final order has been filed and is expected to be heard by the Court on April 19, 2017. Closing of the transaction is expected shortly after receipt of the final court order and all regulatory approvals.

In the interim, Lexam VG Share Owners should complete and return the letters of transmittal that have been sent to them along with the shareholder meeting materials.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.